← Eichor
Condition: Ddi Drug Drug Interaction Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Ddi Drug Drug Interaction

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs
Phase 1 · 1 location(s) · Daewon Pharmaceutical Co., Ltd. · NCT07343245Drug-Drug Intercations and Direct Acting Antiviral Agents Against HCV
Phase N/A · 4 location(s) · University of Seville · NCT06928259A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, R
Phase 1 · 5 location(s) · PMV Pharmaceuticals, Inc · NCT07372625A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, a
Phase 1 · 5 location(s) · Novartis Pharmaceuticals · NCT07340190to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin
Phase 1 · 1 location(s) · Onconic Therapeutics Inc. · NCT07265466Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination
Phase 1 · 1 location(s) · Basilea Pharmaceutica · NCT06733675A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuva
Phase 1 · 1 location(s) · Otsuka Pharmaceutical Development & Commercialization, Inc. · NCT07446400Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors
Phase 4 · 2 location(s) · Rigel Pharmaceuticals · NCT07704658Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessm
Phase 1 · 1 location(s) · Bristol-Myers Squibb · NCT07629999Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects
Phase 1 · 1 location(s) · Modern Biosciences Ltd · NCT06379958Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Phase 4 · 2 location(s) · Rigel Pharmaceuticals · NCT07486713Drug-Drug Interaction Study of ABP-671 in Gout Patients
Phase 1 · 1 location(s) · Atom Therapeutics Co., Ltd · NCT07367971A Study to Investigate the Effect of the CYP3A Inducer Phenytoin and the CYP3A Inhibitor Itraconazole on the Pharmacokin
Phase 1 · 1 location(s) · BeOne Medicines · NCT07590102
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.